Table 1.
Description of patients evaluated in this study.
| Treatment Site | PTV1 Rx | PTV2 Rx | PTV3 Rx | Fractions |
|---|---|---|---|---|
| Supraglottis | 70 Gy | 56 Gy | N/A | 35 |
| Base of Tongue | 70 Gy | 56 Gy | N/A | 35 |
| Soft Palate | 70 Gy | 56 Gy | N/A | 35 |
| Nasopharynx | 70 Gy | 60 Gy | 54 Gy | 33 |
| Oropharynx | 70 Gy | 60 Gy | 54 Gy | 33 |
| Larynxa | 70 Gy | 60 Gy | 54 Gy | 35 |
The Larynx patient was not treated at our institution and the Rx was defined for the purposes of this study to match our clinical protocols.